Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery.
Madoka IwaseMasataka SawakiMasaya HattoriAkiyo YoshimuraJunko IshiguroHaruru KotaniNaomi GondoYayoi AdachiAyumi KataokaSakura OnishiKayoko SuginoHiroji IwataPublished in: Breast cancer (Tokyo, Japan) (2018)
Predicting residual lesions after preoperative chemotherapy by using MRI and US is a reasonable strategy. However, current methods are inadequate for identifying patients who can omit surgery; therefore, a new strategy for detecting small tumors in these patients is needed.
Keyphrases
- minimally invasive
- end stage renal disease
- coronary artery bypass
- contrast enhanced
- magnetic resonance imaging
- patients undergoing
- ejection fraction
- newly diagnosed
- locally advanced
- chronic kidney disease
- surgical site infection
- peritoneal dialysis
- diffusion weighted imaging
- prognostic factors
- squamous cell carcinoma
- coronary artery disease
- magnetic resonance
- rectal cancer
- percutaneous coronary intervention
- patient reported